piperidines has been researched along with methyl-iodide* in 4 studies
4 other study(ies) available for piperidines and methyl-iodide
Article | Year |
---|---|
Improved synthesis and radiolabeling of [11C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET.
An improved synthesis of the precursor acetic acid-piperidine-4-yl ester by acetylation of 4-hydroxypiperidine hydrochloride in anhydrous chloroform was developed. A procedure for fast evaluation and characterization of products originated by acetylation of the 4-piperidinol using LC-APCI/MS with an acetonitrile-water gradient method on a Merck Purosphere RP-18 column was also developed. The highly purified precursor allowed the production of [11C]MP4A for PET studies of acetylcholine neurotransmission system. The tracer was produced with >98% radiochemical purity, with yields ranging 20-60% (decay-corrected) from EOB. Topics: Acetates; Acetylation; Acetylcholinesterase; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Humans; Hydrocarbons, Iodinated; Isotope Labeling; Magnetic Resonance Spectroscopy; Piperidines; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Radiosynthesis of [11C]Lu 29-024: a potential radiotracer for 5HT2 receptors PET studies.
For mapping 5-HT2 receptors in the central nervous system with positron emission tomography (PET), 2,5-dimethyl-3-(4-fluorophenyl)-1-(1-[11C]methyl-4-piperidinyl)-1H-indol e ([11C]Lu29-024) has been prepared. The precursor for the radiosynthesis of [11C]Lu29-024 was obtained in an overall yield of 53% by a convenient five-step synthesis; its reaction with [11C]methyl iodide afforded [11C]Lu29-024 in 35-50% radiochemical yield (decay corrected) in 45 to 50 min with a specific radioactivity ranging from 11 to 15 GBq/micromol. Following i.v. injections into rats, the analysis of plasma samples showed that the metabolism of [11C]Lu29-024 was rapid and extensive (60% of the original tracer was metabolized at 40 min). In contrast, only unmetabolized [11C]Lu29-024 could be detected in brain tissue. These biological results suggest that labeled metabolites have no access to brain tissue and further propose [11C]Lu29-024 as an interesting tool for PET studies of brain 5HT2 receptors. Topics: Animals; Brain; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Hydrocarbons, Iodinated; Indoles; Isotope Labeling; Male; Piperidines; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Tomography, Emission-Computed | 1998 |
[11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography.
The highly selective 5-HT2A receptor antagonist, MDL 100907 ((R)-(+)-4 -(l-hydroxy-1-(2,3-dimethoxyphenyl)methyl)-N -2-(4-fluorophenylethyl)piperidine), was labeled with 11C for Positron Emission Tomography (PET) studies. After i.v. injection of (R)-(+)-[3-OCH3-11C]MDL 100907 [11C]MDL 100907) in Cynomolgus monkeys a marked accumulation in the 5-HT2A receptor rich neocortical regions was obtained with a neocortex to cerebellum ratio of 3.5-4.5 after 60-80 minutes. In the neocortical regions a transient equilibrium occurred within 40-60 minutes. Radioactivity in the neocortex, but not in the cerebellum, was reduced after injection of ketanserin, indicating that neocortical radioactivity following injection of [11C]MDL 100907 represents specific binding to 5-HT2A receptors. There was no evident effect on neocortical binding after pretreatment with raclopride or SCH 23390. [11C]MDL 100907 has potential to become the first selective radioligand for PET-quantitation of 5-HT2A receptors in the human brain in vivo. Topics: Animals; Brain; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Fluorobenzenes; Hydrocarbons, Iodinated; Isotope Labeling; Macaca fascicularis; Methylation; Piperidines; Radioligand Assay; Receptors, Serotonin; Serotonin Antagonists; Tomography, Emission-Computed | 1996 |
Radiosynthesis of [11C]brofaromine, a potential tracer for imaging monoamine oxidase A.
Brofaromine (4-5(-methoxy-7-bromobenzofuranyl)-2-piperidine-HCl) is a potent and selective inhibitor of monoamine oxidase (MAO) A. Two methods for its synthesis and a preliminary positron emission tomography (PET) evaluation in monkey brain are described. The first method, at low carrier concentration of CO2, consisted of direct O-methylation of (4-(5-hydroxy-7-bromobenzofuranyl)-2-piperidine). The total radiochemical yield achieved ranged from 30 to 50% (from end of bombardment [EOB] and decay corrected) with an overall synthesis time of 45 min. The second approach, with high carrier amounts of CO2 arising from inherent target problems, was accomplished in a three-step route involving protection of secondary amino functionality, O-methylation and deprotection. The total radiochemical yield was 10% (from EOB and decay corrected) with a total synthesis time of 70 min. For both methods methylation was achieved using the classical methylating agent [11C]CH3I, and radiochemical purity was higher than 98%. PET evaluation of the radioligand in a Rhesus monkey showed a high uptake of radioactivity in the brain. Using the irreversible MAO-A inhibitor clorgyline and reversible MAO-A inhibitors moclobemide and brofaromine, three blockade experiments were designed to determine the extent of specific binding of [11C]brofaromine to MAO-A. No apparent decrease in accumulation of radioactivity in the monkey brain was observed when compared to a baseline scan. Topics: Animals; Benzamides; Brain; Carbon Radioisotopes; Clorgyline; Female; Hydrocarbons, Iodinated; Indicators and Reagents; Isoenzymes; Isotope Labeling; Macaca mulatta; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Piperidines; Tomography, Emission-Computed | 1996 |